Aethlon Medical (AEMD) Financials

$1.43

$-0.04 (-2.72%)

As on 16-Sep-2026 16:00EDT

Market cap

$1 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Operating Revenue	--	--	--	--	0.57	0.29
Cost of Revenue	0.54	--	0.34	0.36	0.27	4,625.80
Gross Profit	-0.54	--	-0.34	-0.36	0.57	0.29
Operating Expenses	6.69	7.29	9.34	12.64	12.47	10.72
Operating Profit (EBIT)	-7.08	-7.29	-9.34	-12.64	-11.90	-10.42
Other Income	--	--	--	--	--	--
Profit before Tax	-6.94	-7.15	-13.39	-12.21	-12.03	-10.42
Provision for Tax	--	--	--	0.00	131.15	0.00
Profit after Tax (Net Income)	-6.94	-7.15	-13.39	-12.21	-12.03	-10.42
Minority Interest	--	--	--	--	0.00	0.00
Consolidated Profit	--	--	--	--	-12.03	-10.42

Liabilities ($ Mln)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Shareholder's Funds	5.20	4.89	5.12	5.77	15.06	17.13
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	0.34	0.65	0.94	0.60
Current Liabilities	1.04	1.45	1.90	1.83	1.51	1.82
Total Liabilities	7.27	6.33	7.36	8.25	17.51	19.42

Assets ($ Mln)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Non-Current Assets	0.62	0.76	1.41	2.02	2.42	1.26
Current Assets	5.61	5.57	5.95	6.23	15.09	18.16
Total Assets	11.85	6.33	7.36	8.25	17.51	19.42
Total Debt*	0.37	0.34	0.65	0.94	1.21	0.73
Net Current Assets	--	4.12	4.05	4.40	13.59	16.33

Cashflow ($ Mln)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Cash From Operating Activities	--	-7.00	-7.65	-10.13	-10.51	-9.77
Cash Flow from Investing Activities	--	0.00	--	-0.25	-0.94	-0.35
Cash from Financing Activities	--	6.52	7.73	1.29	8.91	17.37
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Adjusted EPS ($)	-11.71	-5.67	-73.64	-373.34	-419.16	-542.50
Cash EPS ($)	--	-5.42	-71.77	-362.36	-410.76	-536.06
Adjusted Book Value ($)	--	3.88	28.18	176.34	524.89	892.35
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-5.55	-42.05	-309.78	-366.03	-508.71
Free Cash Flow per Share ($)	--	-5.55	-42.05	-317.45	-398.89	-526.89

Profitability Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
ROCE (%)	--	-130.07	-214.55	-106.25	-70.48	-76.21
ROE (%)	-116.48	-142.89	-245.88	-117.21	-74.73	-78.42
ROA (%)	-73.88	-104.46	-171.58	-94.80	-65.15	-69.24
EBIT Margin (%)	--	--	--	--	-2,094.89	-3,542.53
Net Margin (%)	--	--	--	--	-2,094.89	-3,540.90
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Revenue Growth (%)	--	--	--	-1.00	0.95	-0.55
EBIT Growth (%)	44.44	46.65	-9.58	-1.48	-15.44	-32.08
Net Profit Growth (%)	44.85	46.58	-9.66	-1.48	-15.49	-32.72
EPS Growth (%)	83.04	0.92	0.80	0.11	0.23	-0.26
Book Value Growth (%)	-18.04	--	--	--	--	--

Valuation Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Price / Earnings	--	-0.39	0.00	0.00	0.00	0.00
Price / Book Value	0.21	0.57	0.01	0.01	0.00	0.00
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	44.52	0.28	0.37	0.38	1.13	1.58
Close Price ($)	4.12	10.95	143.20	672.00	1,530.00	5,840.00
High Price ($)	137.00	176.00	716.00	2,880.00	9,840.00	49,960.00
Low Price ($)	3.98	6.80	95.00	560.00	900.00	4,480.00
Market Cap ($ Cr)	1.09	--	--	--	--	--

Solvency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Debt to Equity	--	0.07	0.13	0.16	0.08	0.04
Short term debt to equity ratio	0.07	0.07	0.06	0.05	0.02	0.01
Current Ratio	5.42	3.85	3.13	3.40	10.03	9.95
Quick Ratio	5.42	--	--	--	--	--
Interest Coverage	-481.71	-496.60	-1,323.37	--	-0.09	-84.25

Operating Efficiency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Debtors to sales (%)	--	--	--	--	--	43.50
Asset Turnover	--	--	--	--	0.03	0.02
Receivable days	--	--	--	--	40.70	172.00
Inventory Days	--	--	--	--	--	-26.90
Payable days	--	--	705.84	615.82	642.15	0.03
Cash Conversion Cycle	--	--	--	--	--	145.06

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.